Released Feb 27, 2020, after the close
10-K filed Feb 28, 2020, 59 days after period end · 0001636422-20-000016
Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$43.50M$43.50M derivedno prior Q4 2018 on file+10.3% vs Q3 2019
Net Income-$14.27M-$14.27M derivedno prior Q4 2018 on fileN/M vs Q3 2019
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$13,672,000—
Operating Cash Flowderived-$13,061,000N/M
Free Cash Flowderived-$13,418,000N/M
Margins · derived
Operating margin-31.4%
Net margin-32.8%
What the release said
The release
Same quarter
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|
| Revenue | $43.50M | — |
| Net Income | -$14.27M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR